United States:
Claims Of Patent For Treating Anemia With Iron Carbohydrate Complexes And Denies Motion To Amend Claims, PTAB Litigation Blog
19 January 2017
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
On January 4, 2017, in a final written decision in IPR2015-01490,
the PTAB found 17 claims of a patent directed to methods of
treating iron disorders by administering certain iron carbohydrate
complexes were unpatentable. Further, the PTAB rejected a
contingent motion to amend the claims.
Read the full article at
ptablitigationblog.com.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
Are Your NDAs Up To Date?
Wolf, Greenfield & Sacks, P.C.
Nondisclosure agreements (NDAs) can be used to protect companies' confi dential and trade secret information. But you should resist the urge to have a vendor...
Legal Implications Of New York Times vs. OpenAI
BoyarMiller
The New York Times recently filed a landmark lawsuit against OpenAI and Microsoft, accusing them of copyright infringement in the training of the chatbot ChatGPT which launched just over a year ago.
